Aetna announces agreement to acquire Medicity

Aetna (NYSE: AET) today announced that it has entered into an agreement to acquire Medicity, a health information exchange technology company, headquartered in Salt Lake City, Utah. A leading innovator in provider solutions, Medicity offers a broad range of products and services that enable health systems, hospitals, physician practices and health information exchanges to securely access and exchange health care information, improving the quality and efficiency of patient care and reducing unnecessary health care costs. Medicity markets its products and services locally, regionally and nationally.

“This acquisition will enable Aetna to offer a set of convenient, easy-to-access technology solutions for physicians, hospitals and other health care providers. That, in turn, can help improve the quality and efficiency of patient care”

The purchase price is approximately $500 million. Aetna expects to finance the acquisition with available resources. The transaction is subject to customary closing conditions, including Hart-Scott-Rodino antitrust regulatory approval. The transaction is projected to be neutral to Aetna's financial results in 2011.

Medicity's connected network provides collaboration and coordination of care delivered through a variety of communications tools, which helps physicians and other health care providers get timely clinical information about patients using the platform of their choice. Medicity's health information exchange (HIE) technology reaches more than 760 hospitals, 125,000 physician users and 250,000 end users.

The company has:

  • The largest installed base of enterprise HIE systems for hospitals, physicians and other health care providers;
  • A substantial presence in the emerging state and regional health information exchange marketplaces;
  • A proven track record of implementation. Medicity has demonstrated an ability to connect to many different types of information systems that provide physicians and other users with information necessary to make better informed health care decisions;
  • A flexible technology platform that, combined with Aetna resources, will enable development of new business offerings;
  • A record of sustained, strong growth in recent years.

"This acquisition will enable Aetna to offer a set of convenient, easy-to-access technology solutions for physicians, hospitals and other health care providers. That, in turn, can help improve the quality and efficiency of patient care," said Mark T. Bertolini, Aetna CEO and president. "Strategically, we believe this acquisition will enhance Aetna's capabilities and accelerate our growth in the health information technology and health information exchange space."

"We are excited about joining Aetna, with the shared vision for improving the health care experience for all stakeholders," said James K. 'Kipp' Lassetter, M.D., Medicity chairman and CEO. "The combination of Medicity's connected health care platform for providers with the clinical decision support capabilities of Aetna's ActiveHealth Management subsidiary can help physicians make better decisions in real-time as they collaborate and coordinate care."

Medicity will operate as a separate business within Aetna, under its existing leadership structure.

Source:

Posted in:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

Sign in to keep reading

We're committed to providing free access to quality science. By registering and providing insight into your preferences you're joining a community of over 1m science interested individuals and help us to provide you with insightful content whilst keeping our service free.

or

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Global Alzheimer’s Platform Foundation announces strategic collaboration and partnership with Spear Bio for the transformative Bio-Hermes-002 study